Bioengineered gum could expand treatment options for oral cancer patients

BY THE OPTIMIST DAILY EDITORIAL TEAM

A bioengineered chewing gum cut HPV levels by 93 percent in oral samples from head and neck cancer patients, in new research from the University of Pennsylvania. The same formulation, when loaded with an antimicrobial peptide called protegrin, brought two…

Click here to view the original article.